130
Participants
Start Date
January 1, 2020
Primary Completion Date
October 31, 2024
Study Completion Date
December 31, 2024
Betablocker + ivabradine
Use of maximum tolerated dose of carvedilol and ivabradine to achieve therapeutic heart rate reduction (THR) to 55-65 beats per minute
Betablocker
Use of maximum tolerated dose of carvedilol to achieve targeted heart rate reduction (THR) to 55-65 beats per minute (responder) or inability to reach THR (non responder) with maximum dose of carvedilol, maintaining a minimum MAP of 70 mmHg.
RECRUITING
Postgraduate Institute of Medical Education and Research, Chandigarh
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER